blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2203446

EP2203446 - CHROMENONE DERIVATIVES AND THEIR USE FOR LEUKOTRIENE BIOSYNTHESIS INHIBITION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.08.2011
Database last updated on 25.09.2024
Most recent event   Tooltip19.08.2011Application deemed to be withdrawnpublished on 21.09.2011  [2011/38]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[2010/27]
Inventor(s)01 / GOSSELIN, Francis
126 East Lincoln Avenue
Rahway New Jersey 07065-0907 / US
02 / VYDRA, Vicky
126 East Lincoln Avenue
Rahway New Jersey 07065-0907 / US
 [2010/27]
Representative(s)Horgan, James Michael Frederic
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2010/27]Horgan, James Michael Frederic
Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon
EN11 9BU / GB
Application number, filing date08833922.123.09.2008
[2010/27]
WO2008US10987
Priority number, dateUS20070995525P27.09.2007         Original published format: US 995525 P
[2010/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009042098
Date:02.04.2009
Language:EN
[2009/14]
Type: A1 Application with search report 
No.:EP2203446
Date:07.07.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 02.04.2009 takes the place of the publication of the European patent application.
[2010/27]
Search report(s)International search report - published on:EP02.04.2009
ClassificationIPC:C07D413/12, A61K31/4245, A61P19/02
[2010/27]
CPC:
C07D413/12 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P13/12 (EP); A61P15/06 (EP);
A61P15/10 (EP); A61P17/00 (EP); A61P17/10 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P25/00 (EP); A61P25/06 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P27/14 (EP); A61P35/02 (EP);
A61P37/00 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P5/24 (EP); A61P7/02 (EP);
A61P9/00 (EP); A61P9/10 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/27]
TitleGerman:CHROMENONDERIVATE UND IHRE VERWENDUNG ZUR HEMMUNG VON LEUKOTRIEN-BIOSYNTHESE[2010/27]
English:CHROMENONE DERIVATIVES AND THEIR USE FOR LEUKOTRIENE BIOSYNTHESIS INHIBITION[2010/27]
French:DÉRIVÉS DE CHROMÉNONE ET LEUR UTILISATION POUR L'INHIBITION DE LA BIOSYNTHÈSE DES LEUCOTRIÈNES[2010/27]
Entry into regional phase27.04.2010National basic fee paid 
27.04.2010Designation fee(s) paid 
27.04.2010Examination fee paid 
Examination procedure16.03.2010Amendment by applicant (claims and/or description)
27.04.2010Examination requested  [2010/27]
16.09.2010Despatch of a communication from the examining division (Time limit: M06)
29.03.2011Application deemed to be withdrawn, date of legal effect  [2011/38]
03.05.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/38]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.09.2010
Fees paidRenewal fee
07.09.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XD]WO2006099735  (MERCK FROSST CANADA LTD [CA], et al) [XD] 1-20 * example 7; claims 1-18 *;
 [Y]WO2004108720  (MERCK FROSST CANADA INC [CA], et al) [Y] 1-20 * claims 1-43 *;
 [Y]US5424320  (FORTIN REJEAN [CA], et al) [Y] 1-20 * claims 1-11 *;
 [Y]WO2007038865  (MERCK FROSST CANADA LTD [CA], et al) [Y] 1-20 * claims 1-23 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.